Astrana Health (NASDAQ:ASTH) Shares Gap Up - What's Next?

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $29.29, but opened at $32.00. Astrana Health shares last traded at $32.09, with a volume of 35,865 shares trading hands.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Barclays started coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price on the stock. Bank of America reduced their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th. Stifel Nicolaus dropped their target price on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Robert W. Baird reduced their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Finally, Macquarie raised shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Astrana Health has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Trading Up 2.7 %

The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 1.37 and a beta of 1.04. The business's 50-day moving average price is $32.40 and its 200 day moving average price is $40.03. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). The firm had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. On average, equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Astrana Health during the 4th quarter valued at approximately $40,000. Quarry LP raised its holdings in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after acquiring an additional 471 shares in the last quarter. KBC Group NV boosted its stake in Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after acquiring an additional 1,316 shares during the last quarter. US Bancorp DE grew its holdings in Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after acquiring an additional 4,656 shares in the last quarter. Finally, PharVision Advisers LLC bought a new stake in shares of Astrana Health in the 4th quarter worth about $211,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.